Current understanding of the role of PPARγ in gastrointestinal cancers

Bing Zou1, Liang Qiao, Benjamin C Y Wong

  • 1Department of Medicine; Centre Cancer Research, The University of Hong Kong, Pok Fu Lam Road, Hong Kong.

PPAR Research
|November 4, 2009
PubMed

Insights

Peroxisome proliferator-activated receptor gamma (PPARγ) has varied roles in cancer, and while its activation shows antitumor effects, its precise role in colorectal cancer remains debated. Recent findings suggest potential therapeutic applications for PPARγ agonists in gastrointestinal cancers.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Biology

Background:

  • Peroxisome proliferator-activated receptor gamma (PPARγ) is implicated in cellular processes including inflammation, cell cycle, proliferation, apoptosis, and carcinogenesis, contributing to cellular homeostasis.
  • In vitro studies demonstrate that ligand-induced activation of PPARγ exhibits antitumor effects in various cancers, including colorectal cancer (CRC).
  • However, the specific role of PPARγ in gastrointestinal cancers, particularly CRC, is a subject of ongoing controversy.

Purpose of the Study:

  • To review recent developments concerning the role of PPARγ in gastrointestinal cancers.
  • To discuss the potential therapeutic applications of PPARγ agonists in cancer prevention and treatment.

Main Methods:

  • Literature review of recent studies on PPARγ in gastrointestinal cancers.
  • Analysis of in vitro and in vivo data regarding PPARγ activation and its effects.

Main Results:

  • PPARγ activation has demonstrated antitumor effects in numerous cancer types.
  • Recent studies suggest potential benefits of PPARγ ligands like Bezafibrate and Rosiglitazone in gastrointestinal cancers.
  • The precise role of PPARγ in colorectal cancer requires further elucidation due to conflicting evidence.

Conclusions:

  • PPARγ agonists show promise for cancer prevention and therapy in gastrointestinal malignancies.
  • Further research is warranted to clarify the controversial role of PPARγ in colorectal cancer and optimize therapeutic strategies.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...